MAM and C99, key players in the pathogenesis of Alzheimer's disease

被引:20
|
作者
Pera, Marta [1 ,2 ]
Montesinos, Jorge [1 ,3 ]
Larrea, Delfina [1 ]
Agrawal, Rishi R. [4 ]
Velasco, Kevin R. [1 ]
Stavrovskaya, Irina G. [1 ]
Yun, Taekyung D. [1 ]
Area-Gomez, Estela [1 ,3 ,4 ]
机构
[1] Columbia Univ, Irving Med Ctr, Dept Neurol, New York, NY 10027 USA
[2] Univ Int Catalunya, Fac Med & Hlth Sci, Dept Basic Sci, Barcelona, Spain
[3] Columbia Univ, Irving Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA
[4] Columbia Univ, Irving Med Ctr, Inst Human Nutr, New York, NY 10027 USA
来源
METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES | 2020年 / 154卷
关键词
MITOCHONDRIA-ASSOCIATED MEMBRANES; POSITRON EMISSION TOMOGRAPHY; CULTURED SKIN FIBROBLASTS; GENOME-WIDE ASSOCIATION; CYTOCHROME-C-OXIDASE; APP/PS1 MOUSE MODEL; ENDOPLASMIC-RETICULUM; AMYLOID-BETA; OXIDATIVE STRESS; A-BETA;
D O I
10.1016/bs.irn.2020.03.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inter-organelle communication is a rapidly-expanding field that has transformed our understanding of cell biology and pathology. Organelle-organelle contact sites can generate transient functional domains that act as enzymatic hubs involved in the regulation of cellular metabolism and intracellular signaling. One of these hubs is located in areas of the endoplasmic reticulum (ER) connected to mitochondria, called mitochondria-associated ER membranes (MAM). These MAM are transient lipid rafts intimately involved in cholesterol and phospholipid metabolism, calcium homeostasis, and mitochondrial function and dynamics. In addition, gamma-secretase-mediated proteolysis of the amyloid precursor protein 99-aa C-terminal fragment (C99) to form amyloid beta also occurs at the MAM. Our most recent data indicates that in Alzheimer's disease, increases in uncleaved C99 levels at the MAM provoke the upregulation of MAM-resident functions, resulting in the loss of lipid homeostasis, and mitochondrial dysfunction. Here, we discuss the relevance of these findings in the field, and the contribution of C99 and MAM dysfunction to Alzheimer's disease neuropathology.
引用
收藏
页码:235 / 278
页数:44
相关论文
共 50 条
  • [11] A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease
    Area-Gomez, Estela
    de Groof, Ad
    Bonilla, Eduardo
    Montesinos, Jorge
    Tanji, Kurenai
    Boldogh, Istvan
    Pon, Liza
    Schon, Eric A.
    CELL DEATH & DISEASE, 2018, 9
  • [12] A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease
    Estela Area-Gomez
    Ad de Groof
    Eduardo Bonilla
    Jorge Montesinos
    Kurenai Tanji
    Istvan Boldogh
    Liza Pon
    Eric A. Schon
    Cell Death & Disease, 9
  • [13] Retention of the Alzheimer's amyloid precursor fragment C99 in the endoplasmic reticulum prevents formation of amyloid β-peptide
    Maltese, WA
    Wilson, S
    Tan, YZ
    Suomensaari, S
    Sinha, S
    Barbour, R
    McConlogue, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) : 20267 - 20279
  • [14] Key brain cell interactions and contributions to the pathogenesis of Alzheimer's disease
    Saavedra, Joana
    Nascimento, Mariana
    Liz, Marcia A.
    Cardoso, Isabel
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [15] Vascular nitric oxide: A key molecule in the pathogenesis of Alzheimer's disease?
    Torre, JCD
    Aliev, G
    NEUROBIOLOGY OF AGING, 2004, 25 : S50 - S50
  • [16] Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and -secretase processing of the C99 peptide
    Tang, Tzu-Chun
    Kienlen-Campard, Pascal
    Hu, Yi
    Perrin, Florian
    Opsomer, Remi
    Octave, Jean-Noel
    Constantinescu, Stefan N.
    Smith, Steven O.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (15) : 5854 - 5866
  • [17] Pathogenesis of Alzheimer's Disease
    Rostagno, Agueda A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [18] The pathogenesis of Alzheimer's disease
    Terry, RD
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 1 - 5
  • [19] The pathogenesis of Alzheimer's disease
    Golde, Todd E.
    CNS SPECTRUMS, 2007, 12 (01) : 4 - 6
  • [20] The pathogenesis of Alzheimer's disease
    Small, GW
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 : 7 - 14